Embecta

Yahoo Finance • 9 hours ago

Yacktman Asset Management's Strategic Moves: A Closer Look at PayPal Holdings Inc.

This article first appeared on GuruFocus. Insightful Analysis of Yacktman Asset Management (Trades, Portfolio)'s Latest 13F Filing Is CNQ fairly valued? Test your thesis with our free DCF calculator. Yacktman Asset Management (Trades, P... Full story

Yahoo Finance • 10 days ago

Yacktman Fund's Strategic Moves: Significant Reduction in Samsung Electronics Co Ltd

This article first appeared on GuruFocus. Exploring Yacktman Fund (Trades, Portfolio)'s Recent Investment Adjustments Warning! GuruFocus has detected 4 Warning Signs with XPAR:BOL. Is XPAR:BOL fairly valued? Test your thesis with our fre... Full story

Yahoo Finance • last month

Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility

[Black Bull and Bear] peterschreiber.media/iStock via Getty Images Small-cap outperformance has narrowed over the last couple of weeks as investor caution increased, with volatility and geopolitical risk weighing on risk appetite and narr... Full story

Yahoo Finance • 3 months ago

embecta names new Chairman of the Board and Lead Independent Director

Embecta Corp. PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today... Full story

Yahoo Finance • 3 months ago

Embecta (EMBC) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. Date Thursday, Feb. 5, 2026 at 8 a.m. ET Call participants President and Chief Executive Officer — Devdatt Kurdikar Chief Financial Officer — Jake Elguicze Vice President, Investor Relations — Pravesh Kha... Full story

Yahoo Finance • 3 months ago

embecta Announces Quarterly Cash Dividend

Embecta Corp. PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s co... Full story

Yahoo Finance • 3 months ago

Yacktman Fund's Strategic Moves: A Closer Look at Samsung Electronics Co Ltd

This article first appeared on GuruFocus. Insights from the Fourth Quarter of 2025 Yacktman Fund (Trades, Portfolio) recently submitted the N-PORT filing for the fourth quarter of 2025, providing insights into its investment moves during... Full story

Yahoo Finance • 4 months ago

embecta to Participate at the J.P. Morgan 2026 Healthcare Conference

Embecta Corp. PARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026... Full story

Yahoo Finance • 5 months ago

Stocks making the biggest moves midday: Dell, Arrowhead Pharmaceuticals, Urban Outfitters & more

Check out the companies making the biggest moves midday: Arrowhead Pharmaceuticals — The stock popped 19% after the biopharmaceutical company reported fiscal year revenue that beat analyst expectations. Arrowhead's top line for the period... Full story

Yahoo Finance • 5 months ago

Embecta declares $0.15 dividend

* Embecta (EMBC [https://seekingalpha.com/symbol/EMBC]) declares $0.15/share quarterly dividend [https://seekingalpha.com/pr/20319346-embecta-announces-quarterly-cash-dividend], in line with previous. * Forward yield [https://seekingal... Full story

Yahoo Finance • 5 months ago

Embecta gives mixed Q4 numbers, gives 2026 guidance

* Embecta press release [https://seekingalpha.com/pr/20319346-embecta-announces-quarterly-cash-dividend] (EMBC [https://seekingalpha.com/symbol/EMBC]): Q4 Non-GAAP EPS of $0.50 beats by $0.04. * Revenue of $263.3M (-8.0% Y/Y) misses by... Full story

Yahoo Finance • 5 months ago

Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance

PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month periods ended September 30, 2... Full story

Yahoo Finance • 5 months ago

embecta announces changes to Board of Directors

PARSIPPANY, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced th... Full story

Yahoo Finance • 6 months ago

embecta Announces Major New Commitment to Direct Relief on World Diabetes Day

PARSIPPANY, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- On World Diabetes Day, embecta Corp. (“embecta”) (Nasdaq: EMBC), the largest manufacturer of insulin injection devices in the world, today announced a significant expansion of its partn... Full story

Yahoo Finance • 8 months ago

Insulin Delivery Device Company Evaluation Report 2025 | Embecta, Novo Nordisk, and Ypsomed Lead with Innovative Injection and Digital Management Solutions

Company Logo The Insulin Delivery Devices Companies Quadrant presents a detailed analysis of the global insulin delivery devices market, spotlighting the top 25 companies like Embecta Corp, Novo Nordisk, and Ypsomed as quadrant leaders. T... Full story

Yahoo Finance • 8 months ago

embecta to Participate in Investor Events

PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced th... Full story

Yahoo Finance • 9 months ago

Mizuho raises Embecta stock price target to $14 on strong Q3 results

Investing.com - Mizuho raised its price target on Embecta (NASDAQ:EMBC) to $14.00 from $12.00 on Monday, while maintaining a Neutral rating on the medical device company’s stock. According to InvestingPro data, the company currently trad... Full story

Yahoo Finance • 9 months ago

Embecta Corp (NASDAQ:EMBC) Surpasses Q3 Earnings Estimates, Shares Jump 10.5% in Pre-Market Trading

Embecta Corp (NASDAQ:EMBC [https://www.chartmill.com/stock/quote/EMBC]) reported its third-quarter fiscal 2025 earnings, surpassing analyst expectations on both revenue and earnings per share (EPS). The company’s performance has triggered... Full story

Yahoo Finance • 9 months ago

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results

PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2025. "Q... Full story

Yahoo Finance • 9 months ago

embecta to Report Fiscal Third Quarter 2025 Financial Results

PARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a confer... Full story